Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (241-250 of 304) with videos related to

Pageof 31
Sort By:
Diabetes|October 27, 2006
Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesityHelen N Lyon, Jose C Florez, Todd Bersaglieri, et al.
Diabetes|November 25, 2004
Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetesJose C Florez, Marketa Sjögren, Noël Burtt, et al.
European Heart Journal|November 20, 2024
Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE studyGurleen Kaur, Robert S Rosenson, Baris Gencer, et al.
Diabetes|December 29, 2005
High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 peopleJose C Florez, Steven Wiltshire, Christina M Agapakis, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Lancet (London, England)|March 16, 2010
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J Raal, Raul D Santos, Dirk J Blom, et al.
Diabetes|July 28, 2005
Association of common variation in the HNF1alpha gene region with risk of type 2 diabetesWendy Winckler, Noël P Burtt, Johan Holmkvist, et al.
The New England Journal of Medicine|July 30, 2015
Antisense Inhibition of Apolipoprotein C-III in Patients with HypertriglyceridemiaDaniel Gaudet, Veronica J Alexander, Brenda F Baker, et al.
Atherosclerosis|January 8, 2026
Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemiaRobert S Rosenson, Eliot A Brinton, Daniel Gaudet, et al.
JACC. Advances|June 28, 2024
The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaFrederick J Raal, Robert S Rosenson, Laurens F Reeskamp, et al.
Pageof 31

Showing results (241-250 of 304) with videos related to

Sort By:
Pageof 31
Diabetes|October 27, 2006
Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesityHelen N Lyon, Jose C Florez, Todd Bersaglieri, et al.
Diabetes|November 25, 2004
Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetesJose C Florez, Marketa Sjögren, Noël Burtt, et al.
European Heart Journal|November 20, 2024
Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE studyGurleen Kaur, Robert S Rosenson, Baris Gencer, et al.
Diabetes|December 29, 2005
High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 peopleJose C Florez, Steven Wiltshire, Christina M Agapakis, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Lancet (London, England)|March 16, 2010
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J Raal, Raul D Santos, Dirk J Blom, et al.
Diabetes|July 28, 2005
Association of common variation in the HNF1alpha gene region with risk of type 2 diabetesWendy Winckler, Noël P Burtt, Johan Holmkvist, et al.
The New England Journal of Medicine|July 30, 2015
Antisense Inhibition of Apolipoprotein C-III in Patients with HypertriglyceridemiaDaniel Gaudet, Veronica J Alexander, Brenda F Baker, et al.
Atherosclerosis|January 8, 2026
Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemiaRobert S Rosenson, Eliot A Brinton, Daniel Gaudet, et al.
JACC. Advances|June 28, 2024
The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial HypercholesterolemiaFrederick J Raal, Robert S Rosenson, Laurens F Reeskamp, et al.
Pageof 31